Dr. Bosch on the HPV Vaccination in the Prevention of Cervical Cancer
Xavier Bosch, MD, MPH
Xavier Bosch, MD, MPH, Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Institut Catala d' Oncologia–Catalan Institute of Oncology, introduces a second-generation vaccination against the human papilloma virus (HPV) for the prevention of cervical cancer.
A second-generation HPV vaccine has arrived in Europe, states Bosch. This vaccine protects against 7 of the HPV types that cause cervical cancer, as well as other HPV-related malignancies in males and females.